Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022

BACKGROUND: As COVID-19 vaccine effectiveness against SARS-CoV-2 infection was lower for cases of the Omicron vs the Delta variant, understanding the effect of vaccination in reducing risk of hospitalisation and severe disease among COVID-19 cases is crucial. AIM: To evaluate risk reduction of hospi...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Baz, Iván, Trobajo-Sanmartín, Camino, Miqueleiz, Ana, Casado, Itziar, Navascués, Ana, Burgui, Cristina, Ezpeleta, Carmen, Castilla, Jesús, Guevara, Marcela, Fernández-Huerta, Miguel, Martín, Carmen, Portillo, María Eugenia, Estévez, Ingrid, Tordoya, Igberto, Quílez, Delia, Lameiro, Francisco, Álvaro, Ana Isabel, Ardanaz, Eva, Baigorria, Fernando, Barricarte, Aurelio, Egüés, Nerea, Cenoz, Manuel García, Iriarte, Nerea, Moreno-Iribas, Conchi, Sayón, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896606/
https://www.ncbi.nlm.nih.gov/pubmed/36729113
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.5.2200337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896606/
https://www.ncbi.nlm.nih.gov/pubmed/36729113
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.5.2200337

Ejemplares similares